은 창상 피복재 시장 기회, 성장 촉진요인, 산업 동향 분석, 예측(2024-2032년)

The Global Silver Wound Dressing Market, valued at USD 1 billion in 2023, is projected to grow at a CAGR exceeding 5.8% from 2024 to 2032, driven by rising chronic wound cases, an increase in surgeries, and innovations in wound care. Advancements in wound care technology, particularly in silver-based dressings such as hydrocolloid, foam, and alginate types, enhance antimicrobial effectiveness and moisture retention, fostering an optimal healing environment. These innovations also boost patient comfort and simplify applications, further propelling market growth.

The growing elderly population, at higher risk of chronic injuries and ulcers, owing to conditions like diabetes and reduced mobility, fuels the demand for silver wound dressings. Product types in this market include sheets, gels & creams, foams, and more. Silver dressing sheets, valued at USD 367.9 million in 2023, lead the market due to their extensive antimicrobial coverage, ease of use, and long-lasting effects, making them ideal for chronic wound care. Recent developments in these sheets, like controlled silver ion release and multi-layered designs, further improve hygiene and odor control, supporting their rising preference in wound management.

The end-user segment comprises hospitals & clinics, ambulatory surgical centers, and home care settings, with hospitals & clinics dominating at USD 527.7 million in 2023. Hospitals increasingly adopt silver dressings to mitigate risks associated with SSIs, reduce recovery complications, and streamline high-risk wound care protocols. This adoption aligns with clinical guidelines, which emphasize the efficacy of silver dressings in complex wound management, supporting market expansion.

The silver wound dressing market, segmented by indication, includes surgical wounds, burns, ulcers, lacerations and cuts, skin grafts, and other wound types. In 2023, the surgical wounds segment held a significant 31.3% market share, largely due to a global increase in surgeries related to lifestyle diseases, trauma, and elective procedures. Demand for advanced wound care solutions, including silver dressings, has risen alongside this trend.

The U.S. market is set to grow at a 5.7% CAGR, reaching USD 666.6 million by 2032. The high incidence of hospital-acquired infections (HAIs) is a significant driver, as silver wound dressings are widely used in infection prevention, especially in post-operative care. Endorsements from the CDC and U.S. FDA to reduce antibiotic reliance and use antimicrobial dressings bolster the preference for silver-based wound care products, fueling market growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing incidence of chronic wounds and surgical procedures
    • 3.2.1.2 Advancement in wound care technology
    • 3.2.1.3 Increase in burn injuries and trauma cases
    • 3.2.1.4 Rising awareness and preference for advanced wound care solutions
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Availability of alternative treatment
    • 3.2.2.2 Risk of cytotoxicity
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Future market trends
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Sheets
• 5.3 Gels & creams
  • 5.3.1 Alginate
  • 5.3.2 Hydrogel
  • 5.3.3 Silver sulfadiazine
  • 5.3.4 Other gels & creams
• 5.4 Foams
• 5.5 Other product types

Chapter 6 Market Estimates and Forecast, By Indication, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Surgical wounds
• 6.3 Burns
• 6.4 Ulcers
• 6.5 Lacerations and cuts
• 6.6 Skin grafts
• 6.7 Other indications

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals & clinics
• 7.3 Ambulatory surgical centers
• 7.4 Homecare settings

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 3M Company
• 9.2 Advanced Medical Solutions Group
• 9.3 B Braun Melsungen
• 9.4 Bravida Medical
• 9.5 Convatec
• 9.6 Coloplast
• 9.7 DermaRite Industries
• 9.8 Ethicon (Johnson and Johnson)
• 9.9 Ferris Mfg
• 9.10 Medline Industries,
• 9.11 Monlycke Health Care
• 9.12 Smith & Nephew